Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Che-Jui Lee

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|February 13, 2026
Deep Learning-Based Semantic Segmentation and Classification of Otoscopic Images for Otitis Media Diagnosis and Health PromotionChien-Yi Yang, Che-Jui Lee, Wen-Sen Lai, et al.
Oncology Research and Treatment|May 4, 2021
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral CenterPatrick Schöffski, Iris Timmermans, Hans Wildiers, et al.
Histopathology|April 7, 2021
Mismatch repair deficiency is rare in bone and soft tissue tumorsSuk Wai Lam, Marie Kostine, Noel F C C de Miranda, et al.
Cancers|December 10, 2021
Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" TrialChe-Jui Lee, Elodie Modave, Bram Boeckx, et al.
Biomedicines|April 23, 2022
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue SarcomaBritt Van Renterghem, Agnieszka Wozniak, Ludovica Tarantola, et al.
International Journal of Cancer|April 9, 2026
Urokinase Plasminogen Activator Receptor-Associated Protein (uPARAP) as a Potential Next Generation Molecular Target for Treatment of Gastrointestinal Stromal Tumors (GIST)Chao-Chi Wang, Flavia Paternostro, Agnieszka Wozniak, et al.
International Journal of Molecular Sciences|May 28, 2022
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" TrialChe-Jui Lee, Elodie Modave, Bram Boeckx, et al.
Translational Oncology|February 24, 2026
Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignanciesChao-Chi Wang, Pernille Barkholt, Agnieszka Wozniak, et al.
Sarcoma|August 20, 2021
Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma ResearchChe-Jui Lee, Agnieszka Wozniak, Thomas Van Cann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to CrizotinibChe-Jui Lee, Patrick Schöffski, Elodie Modave, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|February 13, 2026
Deep Learning-Based Semantic Segmentation and Classification of Otoscopic Images for Otitis Media Diagnosis and Health PromotionChien-Yi Yang, Che-Jui Lee, Wen-Sen Lai, et al.
Oncology Research and Treatment|May 4, 2021
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral CenterPatrick Schöffski, Iris Timmermans, Hans Wildiers, et al.
Histopathology|April 7, 2021
Mismatch repair deficiency is rare in bone and soft tissue tumorsSuk Wai Lam, Marie Kostine, Noel F C C de Miranda, et al.
Cancers|December 10, 2021
Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" TrialChe-Jui Lee, Elodie Modave, Bram Boeckx, et al.
Biomedicines|April 23, 2022
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue SarcomaBritt Van Renterghem, Agnieszka Wozniak, Ludovica Tarantola, et al.
International Journal of Cancer|April 9, 2026
Urokinase Plasminogen Activator Receptor-Associated Protein (uPARAP) as a Potential Next Generation Molecular Target for Treatment of Gastrointestinal Stromal Tumors (GIST)Chao-Chi Wang, Flavia Paternostro, Agnieszka Wozniak, et al.
International Journal of Molecular Sciences|May 28, 2022
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" TrialChe-Jui Lee, Elodie Modave, Bram Boeckx, et al.
Translational Oncology|February 24, 2026
Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignanciesChao-Chi Wang, Pernille Barkholt, Agnieszka Wozniak, et al.
Sarcoma|August 20, 2021
Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma ResearchChe-Jui Lee, Agnieszka Wozniak, Thomas Van Cann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to CrizotinibChe-Jui Lee, Patrick Schöffski, Elodie Modave, et al.
Pageof 3